Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beth Davison

Showing results (41-50 of 98) with videos related to

Pageof 10
Sort By:
International Journal of Molecular Sciences|July 13, 2017
Plasma Neutrophil Gelatinase-Associated Lipocalin and Predicting Clinically Relevant Worsening Renal Function in Acute Heart FailureKevin Damman, Mattia A E Valente, Dirk J van Veldhuisen, et al.
European Journal of Heart Failure|September 6, 2024
Impact of age on clinical outcomes and response to serelaxin in patients with acute heart failure: An analysis from the RELAX-AHF-2 trialRiccardo M Inciardi, Laura Staal, Beth Davison, et al.
European Journal of Heart Failure|June 16, 2025
Liver stiffness measurement for non-invasive assessment of central venous pressure in patients with heart failure: A multicentre pilot studyNicolas Girerd, Jan Biegus, Adam Janas, et al.
International Journal of Cardiology|December 16, 2015
Procalcitonin-based indication of bacterial infection identifies high risk acute heart failure patientsBiniyam G Demissei, John G Cleland, Christopher M O'Connor, et al.
ESC Heart Failure|October 8, 2024
Safety and efficacy of up to 60 h of iv istaroxime in pre-cardiogenic shock patients: Design of the SEISMiC trialJan Biegus, Alexander Mebazaa, Marco Metra, et al.
Lancet (London, England)|November 10, 2022
Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trialAlexandre Mebazaa, Beth Davison, Ovidiu Chioncel, et al.
International Journal of Cardiology. Cardiovascular Risk and Prevention|October 9, 2023
Objectively measured medication adherence using assays for carvedilol and enalaprilat in patients with heart failure in Mozambique and NigeriaJulius Chacha Mwita, Andre Joubert, Hadiza Saidu, et al.
The New England Journal of Medicine|October 8, 2010
Rolofylline, an adenosine A1-receptor antagonist, in acute heart failureBarry M Massie, Christopher M O'Connor, Marco Metra, et al.
European Journal of Heart Failure|December 5, 2019
Clinical value of pre-discharge bio-adrenomedullin as a marker of residual congestion and high risk of heart failure hospital readmissionPaloma Pandhi, Jozine M Ter Maaten, Johanna E Emmens, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|June 1, 2025
Safety and efficacy intravenous istaroxime up to 60 hours for patients with pre-cardiogenic shockJan Biegus, Alexandre Mebazaa, Marco Metra, et al.
Pageof 10

Showing results (41-50 of 98) with videos related to

Sort By:
Pageof 10
International Journal of Molecular Sciences|July 13, 2017
Plasma Neutrophil Gelatinase-Associated Lipocalin and Predicting Clinically Relevant Worsening Renal Function in Acute Heart FailureKevin Damman, Mattia A E Valente, Dirk J van Veldhuisen, et al.
European Journal of Heart Failure|September 6, 2024
Impact of age on clinical outcomes and response to serelaxin in patients with acute heart failure: An analysis from the RELAX-AHF-2 trialRiccardo M Inciardi, Laura Staal, Beth Davison, et al.
European Journal of Heart Failure|June 16, 2025
Liver stiffness measurement for non-invasive assessment of central venous pressure in patients with heart failure: A multicentre pilot studyNicolas Girerd, Jan Biegus, Adam Janas, et al.
International Journal of Cardiology|December 16, 2015
Procalcitonin-based indication of bacterial infection identifies high risk acute heart failure patientsBiniyam G Demissei, John G Cleland, Christopher M O'Connor, et al.
ESC Heart Failure|October 8, 2024
Safety and efficacy of up to 60 h of iv istaroxime in pre-cardiogenic shock patients: Design of the SEISMiC trialJan Biegus, Alexander Mebazaa, Marco Metra, et al.
Lancet (London, England)|November 10, 2022
Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trialAlexandre Mebazaa, Beth Davison, Ovidiu Chioncel, et al.
International Journal of Cardiology. Cardiovascular Risk and Prevention|October 9, 2023
Objectively measured medication adherence using assays for carvedilol and enalaprilat in patients with heart failure in Mozambique and NigeriaJulius Chacha Mwita, Andre Joubert, Hadiza Saidu, et al.
The New England Journal of Medicine|October 8, 2010
Rolofylline, an adenosine A1-receptor antagonist, in acute heart failureBarry M Massie, Christopher M O'Connor, Marco Metra, et al.
European Journal of Heart Failure|December 5, 2019
Clinical value of pre-discharge bio-adrenomedullin as a marker of residual congestion and high risk of heart failure hospital readmissionPaloma Pandhi, Jozine M Ter Maaten, Johanna E Emmens, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|June 1, 2025
Safety and efficacy intravenous istaroxime up to 60 hours for patients with pre-cardiogenic shockJan Biegus, Alexandre Mebazaa, Marco Metra, et al.
Pageof 10